Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-adsorbed Cocktail of Recombinant Derivatives of Major Allergens of Timothy Grass (Phleum Pratense).

The trial is performed to assess efficacy and safety of a recombinant grass Pollen allergen cocktail in allergic rhinoconjunctivitis

Inclusion Criteria:

• Positive Skin Prick Test reaction to grass pollen
• Positive RAST result to grass pollen
• Positive Provocation Test result to grass pollen

Exclusion Criteria:

• Serious chronic diseases
• Other relevant perennial allergies